Post by Aptar Digital Health

One theme consistently emerged across conversations at HLTH Europe 2026: the industry is moving beyond collecting data toward understanding the real patient experience behind it. As digital health ecosystems continue to evolve, real world evidence is becoming increasingly valuable in helping pharmaceutical companies better understand how therapies are experienced in patients’ daily lives, across symptoms, adherence, quality of life and long term outcomes. From patient community platforms to connected devices and wearable integrations, digital health solutions are opening new opportunities to generate richer and more continuous patient insights at scale. Thank you to everyone who connected with the Aptar Digital Health team during HLTH Europe 2026. We look forward to continuing these important conversations. Aurore Beaume Marcus Bates Damien McKeon Ronald Nocua #RealWorldEvidence #HLTHEurope